CRYM (crystallin mu)

2009-08-01  

Identity

HGNC
LOCATION
16p12.2
LOCUSID
ALIAS
DFNA40,THBP
FUSION GENES

Other Information

Locus ID:

NCBI: 1428
MIM: 123740
HGNC: 2418
Ensembl: ENSG00000103316

Variants:

dbSNP: 1428
ClinVar: 1428
TCGA: ENSG00000103316
COSMIC: CRYM

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000103316ENST00000219599Q14894
ENSG00000103316ENST00000543948Q14894
ENSG00000103316ENST00000570401I3L3Y1
ENSG00000103316ENST00000571358I3L3J9
ENSG00000103316ENST00000572914I3NI53
ENSG00000103316ENST00000574448I3L2W5
ENSG00000103316ENST00000576703I3L325

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
MetabolismREACTOMER-HSA-1430728
Metabolism of amino acids and derivativesREACTOMER-HSA-71291
Lysine catabolismREACTOMER-HSA-71064
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolismREACTOMER-HSA-6788656

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
384010232024Gene expression patterns of CRYM and SIGLEC10 in Alzheimer's disease: potential early diagnostic indicators.0
384188852024Crym-positive striatal astrocytes gate perseverative behaviour.2
384010232024Gene expression patterns of CRYM and SIGLEC10 in Alzheimer's disease: potential early diagnostic indicators.0
384188852024Crym-positive striatal astrocytes gate perseverative behaviour.2
330340502021Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.10
330340502021Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.10
296034022018Expression of CRYM in different rat organs during development and its decreased expression in degenerating pyramidal tracts in amyotrophic lateral sclerosis.4
296034022018Expression of CRYM in different rat organs during development and its decreased expression in degenerating pyramidal tracts in amyotrophic lateral sclerosis.4
259311622015Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions.10
261735102015Ketimine reductase/CRYM catalyzes reductive alkylamination of α-keto acids, confirming its function as an imine reductase.4
259311622015Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions.10
261735102015Ketimine reductase/CRYM catalyzes reductive alkylamination of α-keto acids, confirming its function as an imine reductase.4
235087172013Possible roles of the AP-1 site in the cytosolic T3 binding protein promoter and insights into its physiological significance.1
235087172013Possible roles of the AP-1 site in the cytosolic T3 binding protein promoter and insights into its physiological significance.1
213327202011Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones.23

Citation

Dessen P

CRYM (crystallin mu)

Atlas Genet Cytogenet Oncol Haematol. 2009-08-01

Online version: http://atlasgeneticsoncology.org/gene/51036/gene-fusions/img/gene-fusions-explorer/